Company Profile

Digital Solution, a Mumbai-based organization, established itself in Indias oncology pharmaceuticals sector in 2017. Primarily a trader and retailer, Digital Solution sells novel anti-cancer medications: brigatinib tablets, quizartinib tablets, capmatinib tablets, dasatinib tablets, sorafenib tablets, sunitinib capsules, infigratinib capsules, and dabrafenib capsules, all of which are sold under license from the respective originator pharmaceutical companies. The entire organization is built around the concepts of innovation, quality, and trust. With professional team members, the organization operates across legal, quality, and ethical lines in daily commercial activity. Each medication is produced following manufacture, importation, and labeling under strict international guidelines for stability, safety, and efficacy. The leadership vision is to ensure that novel, next-generation targeted medical therapies are available under the umbrella of a trust-based relationship between patient and provider. Digital Solution intends to operate on a highly competitive global scale, ensuring excellence in sourcing and distribution, as a promise of improved health care through science.

Key Facts of Digital Solution:

Nature of Business	Trader, Retailer
Location	Mumbai, Maharashtra, India
Year Of Establishment	2017
No. of Employees	10
GST Number	27APYPG9551P1ZP
Annual Turnover	INR 40 Lakh